Clinical characterisation of the CABP4

advertisement
Clinical characterisation of the CABP4-related retinal phenotype
Khan, AO [ 1,2 ]; Alrashed, M [ 2,3,4 ]; Alkuraya, FS [ 2,5,6,7 ]
BRITISH JOURNAL OF OPHTHALMOLOGY
Volume: 97, Issue: 3, Pages: 262-265, Published: MAR 2013
Publisher BMJ PUBLISHING GROUP, BRITISH MED ASSOC HOUSE, TAVISTOCK
SQUARE, LONDON WC1H 9JR, ENGLAND
ISSN: 0007-1161
Abstract
Background Calcium binding protein 4 (CABP4), specifically located in photoreceptor
synaptic terminals, has been associated with congenital stationary night blindness
based on this clinical diagnosis being made for three individuals from two Swiss families
with CABP4 mutations; however, the few reported cases limit phenotype-genotype
correlation. We expand the number of reported patients with CABP4 mutations and
clinically characterise the CABP4-related phenotype.
Methods A retrospective case series of 11 individuals (age 2a 26 years; four
consanguineous families) with early-onset retinal dysfunction found to harbour CABP4
mutations after a strategy of homozygosity analysis and/or candidate gene testing.
Results The 11 patients from four families harboured the same homozygous CABP4
mutation (c.81_82insA; p. Pro28Thrfs*4) and shared a common haplotype. All patients
had congenital nystagmus, stable low vision, photophobia and a normal or near-normal
fundus appearance. None complained of night blindness when specifically questioned.
Eight had hyperopic cycloplegic refractions (>=+ 1.00 dioptre). Electroretinography
showed an electronegative waveform response to scotopic bright flash, near-normal to
subnormal rod function, and delayed and/or decreased cone responses or was nonrecordable. Although these and previously reported families with homozygous mutations
were labelled with different clinical diagnoses, all had similar clinical features.
Conclusion These typical clinical features, which do not include a symptom of night
blindness, suggest CABP4 mutations. The phenotype is best uniformly termed
congenital cone-rod synaptic disorder. In Saudi Arabia a founder homozygous
c.81_82insA CABP4 mutation is a recurrent cause.
Keywords
KeyWords Plus:NIGHT BLINDNESS; CABP4; MUTATIONS; GENE
Author Information
Reprint Address: Khan, AO E-mail Addresses:arif.khan@mssm.edu
King Khalid Eye Specialist Hosp, Div Pediat Ophthalmol, Riyadh 11462, Saudi
Arabia.
Organization-Enhanced Name(s)
King Khaled Eye Specialist Hospital
King Khalid University Hospital
King Saud University
Addresses:
[ 1 ] King Khalid Eye Specialist Hosp, Div Pediat Ophthalmol, Riyadh 11462, Saudi
Arabia
Organization-Enhanced Name(s)
King Khaled Eye Specialist Hospital
King Saud University
King Khalid University Hospital
[ 2 ] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia
Organization-Enhanced Name(s)
King Faisal Specialist Hospital & Research Center
King Faisal Specialist Hospital & Research Center - Riyadh
[ 3 ] King Saud Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Riyadh, Saudi Arabia
Organization-Enhanced Name(s)
King Saud University
[ 4 ] UCL Inst Ophthalmol, Dept Mol Genet, London, England
Organization-Enhanced Name(s)
University College London
University of London
[ 5 ] King Saud Univ, King Khalid Univ Hosp, Dept Pediat, Riyadh, Saudi Arabia
Organization-Enhanced Name(s)
King Khalid University Hospital
King Saud University
[ 6 ] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia
Organization-Enhanced Name(s)
King Saud University
[ 7 ] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh, Saudi Arabia
Organization-Enhanced Name(s)
Alfaisal University
Download